What is the main business of Reumedika?

The main business activity of Reumedika focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 23, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Wejherowska 16, 60-446 Poznań.

Who is on the management board?

The management board consists of: Łukasz Porawski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from November 23, 2023 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $323,428.

Yes, in 2024 the company achieved a net profit of $179,794.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $49,152 in 2024, representing 36% of all operating expenses.

Reumedikasp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-11-23

Share capital

5 000,00 PLN

Activity description

Reumedika is a rheumatology clinic in Poznań that offers consultations with experienced rheumatologists and participates in clinical trials for new medications. The clinic specializes in treating conditions such as rheumatoid arthritis, psoriatic arthritis, and osteoporosis, utilizing biological treatments like Remicade and Humira. Additionally, it provides access to innovative medical therapies and free medical care for participants in clinical studies.

Registered address

ul. Wejherowska 16, 60-446 Poznań, Poland

Website

reumedika.pl

Phone

Social media

Electronic delivery address

AE:PL-82473-73078-UGVDH-27

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 323.43kMedianUSD 72.15kAverageUSD 3.22m

Net profit

This companyUSD 179.79kMedianUSD 87.69AverageUSD 112.20k

Operating costs

This companyUSD 137.54kMedianUSD 75.02kAverageUSD 3.02m

Assets

This companyUSD 195.35kMedianUSD 121.49kAverageUSD 3.89m

Industry

Bank accounts

Registered as a VAT taxpayer on 2023-12-08. Active

PKO Bank Polski
35 1020 4900 0000 8302 3635 4345

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Łukasz Porawski — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Wiesława Porawska (67)	50	$675.31	50%
Łukasz Porawski (42)	50	$675.31	50%

Łukasz Porawski and Wiesława Porawska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights
Wiesława Porawska (67)	Shareholder of a limited liability company, 2500.0 PLN
Łukasz Porawski (42)	Shareholder of a limited liability company, 2500.0 PLN

Competitors

	Name	Revenue	Website
	Centrum Badawcze Panaceum Agnieszka Brzezicka,Magdalena Lenkiewiczsp. z o.o.	$1,087,310.46	klinikabadawcza.pl
	Medrisesp. z o.o.	$571,656.57	medrise.pl

FAQ

Last updated: 2026-04-27